Investigating Pharmacology of Novel DDR Inhibitors to Support Clinical Development
Time: 4:00 pm
day: Day One
Details:
• Implementing models and simulation to improve understanding of second and
third wave DDR inhibitors
• Determining appropriate inhibition levels within a dynamic range for subsequent
lead optimization
• Pre-clinical pharmacology lessons to mitigate haem toxicity of combination
therapies
